Losartan and Metamorphopsia

preprint OA: closed CC-BY-4.0
📄 Open PDF View at publisher

Abstract

Background: Losartan, a commonly used hypertension medication, is associated with rare neurological side effects. This report presents the first case of losartan-linked bilateral metamorphopsia - a distortion of visual perception. Case Presentation: A 65-year-old woman with hypertension and myopic degeneration developed bilateral metamorphopsia while taking losartan. Despite normal retinal exams and neuroimaging, the symptoms persisted. Discontinuation of losartan led to symptom resolution over one year with no recurrence. Conclusions: This unique case emphasizes the need to evaluate drug-related adverse events in clinical diagnoses. Losartan's potential impact on the midbrain's visual processing regions may explain the observed visual disturbances. Further research is needed to explore this connection.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-27T02:00:06.600101+00:00
License: CC-BY-4.0